$3.79
At close: Sep 2, 5:00 PM EST
$3.79
N/A
After Hours: 4:30 PM EST
Camp4 Therapeutics Corp
CAMPNASDAQ
Camp4 Therapeutics Earnings & Forecasts
Camp4 Therapeutics (CAMP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Camp4 Therapeutics Guidance
Camp4 Therapeutics (CAMP) last issued guidance on July 10, 2023 for Q2 2024. The company guided revenue in the range of $67M - $73M for the period.
Compared to prior guidance, Camp4 Therapeutics lowered its revenue forecast from a prior range of $72M - $78M.
Camp4 Therapeutics has issued 2 guidance updates between April 27, 2023 and July 10, 2023. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.21 | $-0.30 | $-0.48 |
| Actual | $-0.58 | $-0.32 | $-0.87 | $-0.55 |
| Surprise | -163.6% | -52.4% | -190.0% | -14.6% |
| Revenue | ||||
| Estimate | $1.8M | $1.2M | $538000 | $651998 |
| Actual | $1.8M | $1.3M | $348000 | $795000 |
| Surprise | -0.17% | +5.51% | -35.3% | +21.9% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.18 | $-0.17 | $-0.17 | $-0.19 |
| Revenue | ||||
| Consensus | $2.4M | $2.4M | — | — |
